The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging.
The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging.
复制标题
抗CD3单克隆抗体的作用机制。
DOI:
10.1097/00007890-199010000-00030
复制
发表时间:
1990
期刊:
影响因子:
6.2
通讯作者:
Colvin,RB
中科院分区:
文献类型:
--
作者:
Wong,JT;Eylath,AA;Ghobrial,I;Colvin,RB
OKT3, an anti-CD3 MAB, depletes T cells in vivo and is among the most potent inhibitors of acute allograft rejection. The mechanism of this inhibition is unknown. The present studies investigate whether anti-CD3 antibodies have the ability to crosslink CD3 on two different cells and induce TCR-dependent antibody-bridged cell-mediated cytolysis (TCR-ABCMC) between T cells. Two different anti-CD3 antibodies (OKT3 and CD3, 3) and OKT3 F (ab') 2 were all highly effective in inducing cytolysis of CD8+ and CD4+ T cells by CD8+ T cells, and CD8+ T cells by CD4+ T cells. Monovalent OKT3 Fab was 25–125-fold less potent than OKT3 F (ab') 2. Monovalent CD3, X was totally ineffective. The necessity for intercellular bridging was evidenced by the observation that an anti-CD3: anti-CD4 (CD3, 4) bispecific MAB (BSMAB) was effective in mediating lysis of CD4+ but not CD8+ T cells by CD8+ T cells. These studies indicate that neither FcR-mediated ADCC nor complement fixation is necessary for bivalent anti-CD3 MAB to lyse T cells. Inter-T cell TCR-ABCMC may be particularly effective in inflammatory tissues, such as rejecting allografts and autoimmune diseases, in which numerous cytolytic T lymphocytes are present in close association with other T cells.